Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.05 USD | +0.83% | -0.16% | +20.40% |
05-15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
05-09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.40% | 735M | |
+7.98% | 114B | |
+9.70% | 104B | |
-1.83% | 22.57B | |
-9.64% | 22.5B | |
-10.39% | 17.95B | |
-41.90% | 16.48B | |
-13.84% | 15.82B | |
+3.05% | 13.55B | |
+29.65% | 10.99B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Transcript : Wave Life Sciences Ltd. - Special Call